LA HR292

Requests the Louisiana Department of Health to study the feasibility of expanding Medicaid coverage for continuous glucose monitoring (CGM) services to all at-risk and qualifying gestational diabetes mellitus patients, not just insulin-dependent patients as currently covered

Gestational diabetes rates in Louisiana's Medicaid population increased from 10.2% to 14.8% in recent years, with risk factors like obesity and sedentary behaviors remaining prevalent

Estimated cost to expand CGM coverage to additional qualifying patients is between $500,000 and $1 million, with potential to use existing incentive-based reimbursement mechanisms between the department, managed care organizations, and hospitals

Department must provide a written report with findings and coverage policy analysis to the House Committee on Health and Welfare by January 1, 2026, unless it elects to update the policy before that date

Unmanaged gestational diabetes can lead to complications including excessive fetal growth, premature births, and respiratory distress for both mother and child